BioNTech SE BNTX
NASDAQ BNTX
$86.28 -1.37 (-1.56%)
As of: Nov 12, 2026 · 11:29 AM EST

BioNTech SE (BNTX) Cost of Revenue (2018 - 2026)

Updated

BioNTech SE (BNTX) reported Cost of Revenue of $118.84 million for Q3 2026, down 31.5% from $173.37 million a year earlier but up 5.4% from the prior quarter.

Analysis

BioNTech SE (BNTX) Cost of Revenue (2018 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, BioNTech SE's Cost of Revenue came in at $703.16 million, up 15.6% year-over-year; for FY2025, it was $725.11 million, up 23.8% from FY2024.

  • Cost of Revenue has a five-year compound annual growth rate of 60.7% (FY2020 to FY2025).
  • By year, Cost of Revenue came in at $585.87 million in FY2024 (-9.7%), $648.81 million in FY2023 (-79.4%), $3.16 billion in FY2022 (-8.4%) and $3.45 billion in FY2021.
  • Five-year quarterly Cost of Revenue spans a low of $64.2 million in Q1 2024 and a high of $1.45 billion in Q1 2022.
  • Year over year, Cost of Revenue gained in five of the last eight quarters, with growth averaging 17.2%.
  • The high point for year-over-year Cost of Revenue in five years was Q4 2025 (growth of 49.1%); the low point was Q1 2023 (a decline of 92.9%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $112.75 million (Q2 2026), $83.59 million (Q1 2026) and $387.98 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 BioNTech SE 22.05 Bn -37.46 Bn 1.36 Bn 118.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 118.84 Mn
Jun 30, 2026 112.75 Mn
Mar 31, 2026 83.59 Mn
Dec 31, 2025 387.98 Mn
Sep 30, 2025 173.37 Mn
Jun 30, 2025 86.48 Mn
Mar 31, 2025 88.15 Mn
Dec 31, 2024 260.20 Mn
Sep 30, 2024 196.47 Mn
Jun 30, 2024 64.40 Mn
Mar 31, 2024 64.20 Mn
Dec 31, 2023 192.70 Mn
Sep 30, 2023 176.13 Mn
Jun 30, 2023 177.39 Mn
Mar 31, 2023 103.04 Mn
Dec 31, 2022 187.22 Mn
Sep 30, 2022 759.03 Mn
Jun 30, 2022 815.87 Mn
Mar 31, 2022 1.45 Bn
Dec 31, 2021 667.16 Mn
API Access

BioNTech SE Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY